AC
AMAG

Amici Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Amici Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-50,000
Closed -$1.04M – 171
2014
Q2 		$1.04M Buy
+50,000
New +$924K 0.03% 124

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Amici Capital's AMAG Position: Q3 2014 in Review

Amici Capital sold out of AMAG Pharmaceuticals (AMAG) in Q3 2014, closing a stake of 50,000 shares — an estimated $1.04M sold.

Amici Capital first reported a position in AMAG in Q2 2014 and held it in 1 quarter. The position peaked at $1.04M in Q2 2014. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2014.

  • Amici Capital reported no remaining AMAG Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Amici Capital sold 50,000 AMAG Pharmaceuticals shares in Q3 2014, an estimated $1.04M.
  • Amici Capital first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 1 quarter.
  • Amici Capital's AMAG Pharmaceuticals position peaked at $1.04M in Q2 2014.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2014.

Based on Amici Capital's 13F filing for Q3 2014, filed 14 Nov 2014.